Aspirin dosage for the prevention of graft occlusion in people undergoing coronary surgery-Reference-Cited by-同舟云学术

Aspirin dosage for the prevention of graft occlusion in people undergoing coronary surgery

Published:2016-03-19 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Alahdab Fares¹,Jazayerli Mhd Luay²,Alhalabi Omar²,Hasan Somar³,Mallak Mahmoud⁴,Alkhouli Mohamad⁵,Haydour Qusay²,Murad M. Hassan⁶

Affiliation:

1. Mayo Clinic; Evidence-based Practice Center; 1919 3rd Ave NE Apt 2 Rochester MN USA 55906

2. University of Damascus; Faculty of Medicine; Damascus Syrian Arab Republic

3. Damascus University; Almwasat University Hospital; Damascus Syrian Arab Republic

4. University of Damascus; Children's University Hospital; Damascus Syrian Arab Republic

5. Mayo Clinic; Rochester USA

6. Mayo Clinic; Preventive Medicine Fellowship, The Knowledge and Encounter Research Unit; 200 First Street SW Rochester MN USA 55905

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD012113/fullpdf

Reference64 articles.

1. Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials;Al Ali;JACC: Cardiovascular Interventions,2014

2. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial;Alexander;JAMA,2005

3. Collaborative overview of randomised trials of antiplatelet therapy - II: maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration;Anonymous;BMJ,1994

4. Statistics notes. Trials randomised in clusters;Bland;BMJ,1997

5. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [in French];Boissel;Therapie,1999